Insights

Expanding Biosimilar Portfolio Intas is rapidly expanding its biosimilar portfolio, highlighted by the recent acquisition of Udenyca and development of biosimilars referencing blockbuster drugs like Opdivo. This positions the company as a strong partner for healthcare providers seeking cost-effective alternatives in high-value therapeutic areas such as oncology and immunology.

Strategic Market Entry With its recent launch of the first globally approved PD-1 inhibitor in India and expansion into regulated markets like the US and EU, Intas offers opportunities to collaborate with hospitals and clinics seeking innovative and approved immuno-oncology treatments at competitive prices.

Regional Coverage & Local Partnerships Intas has a broad international footprint, present in over 85 countries and with subsidiaries across key regions. This extensive network opens avenues for joint ventures, distribution agreements, and local manufacturing partnerships to enhance market penetration and sales in emerging markets.

Focus on High-Growth Therapeutic Segments Intas specializes in prominent therapeutic areas such as CNS, Oncology, Cardio, and Urology. These segments are experiencing high demand, creating opportunities to introduce new formulations, biosimilars, and innovative therapies to healthcare providers and payers worldwide.

Research & Development Investment With a strategic focus on R&D and over 10,000 product registrations, Intas is poised to launch a steady pipeline of high-value, high-margin products. Leveraging these innovations can help partners address unmet medical needs and expand revenue streams through collaborative product development and licensing.

Intas Pharmaceuticals Tech Stack

Intas Pharmaceuticals uses 8 technology products and services including WordPress, Oracle, SAP ERP, and more. Explore Intas Pharmaceuticals's tech stack below.

  • WordPress
    Content Management System
  • Oracle
    Enterprise
  • SAP ERP
    Enterprise Resource Planning
  • MooTools
    Javascript Frameworks
  • Microsoft Azure
    Platform As A Service
  • HSTS
    Security
  • Adobe Creative Suite
    Visualisation Software
  • SVG Support
    Web Platform Extensions

Media & News

Intas Pharmaceuticals's Email Address Formats

Intas Pharmaceuticals uses at least 1 format(s):
Intas Pharmaceuticals Email FormatsExamplePercentage
First_Last@intaspharma.comJohn_Doe@intaspharma.com
94%
FirstLast@intaspharma.comJohnDoe@intaspharma.com
3%
FLast@intaspharma.comJDoe@intaspharma.com
2%
F_Last@intaspharma.comJ_Doe@intaspharma.com
1%

Frequently Asked Questions

Where is Intas Pharmaceuticals's headquarters located?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's main headquarters is located at Sarkhej Gandhinagar Highway, Near Sola Bridge Ahmedabad, Gujarat, IN. The company has employees across 6 continents, including AsiaSouth AmericaNorth America.

What is Intas Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Intas Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Intas Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's official website is intaspharma.com and has social profiles on LinkedInCrunchbase.

How much revenue does Intas Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2025, Intas Pharmaceuticals's annual revenue is estimated to be $5B.

What is Intas Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Intas Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2025, Intas Pharmaceuticals has approximately 18K employees across 6 continents, including AsiaSouth AmericaNorth America. Key team members include Chief Executive Officer: R. J. M.Chief Executive Officer: V. B.Chief Financial Officer: K. G.. Explore Intas Pharmaceuticals's employee directory with LeadIQ.

What industry does Intas Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Intas Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Intas Pharmaceuticals use?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's tech stack includes WordPressOracleSAP ERPMooToolsMicrosoft AzureHSTSAdobe Creative SuiteSVG Support.

What is Intas Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Intas Pharmaceuticals's email format typically follows the pattern of First_Last@intaspharma.com. Find more Intas Pharmaceuticals email formats with LeadIQ.

When was Intas Pharmaceuticals founded?

Minus sign iconPlus sign icon
Intas Pharmaceuticals was founded in 1976.
Intas Pharmaceuticals

Intas Pharmaceuticals

Pharmaceutical ManufacturingIndia10001+ Employees

Intas is one of the leading multinational pharmaceutical formulation development, manufacturing, and marketing organization in the world. It has been growing at 19% CAGR and crossed the $2.5 billion mark in the past financial year. The company has set up a network of subsidiaries, under the name Accord Healthcare in the EU, US, Canada, SA, Australia, APAC as well as CIS & MENA regions. Intas is present in 85+ countries, with more than 70% of its revenue coming from global business.

Currently ranked 6th in the Indian pharmaceutical market, it’s the largest privately owned Indian generic pharma company. Intas has established leadership in key therapeutic segments like CNS, Cardio, Diabeto, Gastro, Urology, Oncology & Animal Health in India. We are among the top 10 generic players in the highly regulated markets of EU, US & UK.

Intas operates 17 advanced formulations, R&D, and distribution facilities, of which 10 are in India and the rest in the UK, Mexico & Greece with the help of our 23,000+ Human Capital. Between them, the facilities are accredited by global regulators such as USFDA, EMA, MHRA, TGA, and others. The company invests ~6-7% of its revenues in R&D and has over 10,000 product registrations worldwide with a strategic pipeline of 300+ high-value FTF/FTM, Biosimilars, and NDDS products.
 
Intas' highly advanced EU-GMP Certified Biopharma division is fueled by a mission to provide affordable “Biosimilars for Billions” across niche segments such as oncology, auto-immune, ophthalmology, nephrology, rheumatology, and hormone-based therapies.

The Plasma Fractionation Unit of Intas Pharmaceuticals is a pioneer in manufacturing plasma-derived therapeutics. It houses a full-fledged R&D lab and a state-of-the-art WHO-GMP-certified manufacturing facility complemented with a GLP-compliant QC lab.

Our values of Innovation, Customer Delight, Ownership & Collaboration, Performance Focus & Care for Society are the driving forces toward excellence.

Section iconCompany Overview

Headquarters
Sarkhej Gandhinagar Highway, Near Sola Bridge Ahmedabad, Gujarat, IN
Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
1976
Employees
10001+

Section iconFunding & Financials

  • $1B$10B

    Intas Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $1B$10B

    Intas Pharmaceuticals's revenue is estimated to be in the range of $1B$10B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.